U.S. flag

An official website of the United States government

NM_003001.5(SDHC):c.118C>G (p.Arg40Gly) AND multiple conditions

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 24, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000695000.11

Allele description [Variation Report for NM_003001.5(SDHC):c.118C>G (p.Arg40Gly)]

NM_003001.5(SDHC):c.118C>G (p.Arg40Gly)

Gene:
SDHC:succinate dehydrogenase complex subunit C [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q23.3
Genomic location:
Preferred name:
NM_003001.5(SDHC):c.118C>G (p.Arg40Gly)
HGVS:
  • NC_000001.11:g.161328436C>G
  • NG_012767.1:g.19061C>G
  • NM_001035511.3:c.118C>G
  • NM_001035512.3:c.77+4766C>G
  • NM_001035513.3:c.21-12158C>G
  • NM_001278172.3:c.77+4766C>G
  • NM_001407115.1:c.118C>G
  • NM_001407116.1:c.61C>G
  • NM_001407117.1:c.61C>G
  • NM_001407118.1:c.77+4766C>G
  • NM_001407119.1:c.7C>G
  • NM_001407120.1:c.7C>G
  • NM_001407121.1:c.61C>G
  • NM_003001.5:c.118C>GMANE SELECT
  • NP_001030588.1:p.Arg40Gly
  • NP_001394044.1:p.Arg40Gly
  • NP_001394045.1:p.Arg21Gly
  • NP_001394046.1:p.Arg21Gly
  • NP_001394048.1:p.Arg3Gly
  • NP_001394049.1:p.Arg3Gly
  • NP_001394050.1:p.Arg21Gly
  • NP_002992.1:p.Arg40Gly
  • NP_002992.1:p.Arg40Gly
  • LRG_317t1:c.118C>G
  • LRG_317:g.19061C>G
  • LRG_317p1:p.Arg40Gly
  • NC_000001.10:g.161298226C>G
  • NM_003001.3:c.118C>G
  • NR_103459.3:n.143C>G
Protein change:
R21G
Links:
dbSNP: rs978019587
NCBI 1000 Genomes Browser:
rs978019587
Molecular consequence:
  • NM_001035512.3:c.77+4766C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001035513.3:c.21-12158C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001278172.3:c.77+4766C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407118.1:c.77+4766C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001035511.3:c.118C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407115.1:c.118C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407116.1:c.61C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407117.1:c.61C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407119.1:c.7C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407120.1:c.7C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407121.1:c.61C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003001.5:c.118C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_103459.3:n.143C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Gastrointestinal stroma tumor
Synonyms:
Gastrointestinal stromal tumor; Gastrointestinal stromal tumor, somatic
Identifiers:
MONDO: MONDO:0011719; MeSH: D046152; MedGen: C0238198; Orphanet: 44890; OMIM: 606764; Human Phenotype Ontology: HP:0100723
Name:
Pheochromocytoma/paraganglioma syndrome 3
Synonyms:
GLOMUS TUMORS, FAMILIAL, 3; Paragangliomas 3; SDHC-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome (Paragangliomas 3)
Identifiers:
MONDO: MONDO:0011544; MedGen: C1854336; Orphanet: 29072; OMIM: 605373

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000823474Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jul 24, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9..

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000823474.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 40 of the SDHC protein (p.Arg40Gly). This variant has not been reported in the literature in individuals affected with SDHC-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 573349).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 11, 2026